Opioid Analgesics Risk Evaluation and Mitigation Strategy (REMS): Education for Healthcare Providers

Access Activity

Overview / Abstract:

Program Overview

Pain is a significant public health problem, affecting more than 100 million adults in the US and causing significant reductions in patients’ quality of life. The use of narcotic medications for pain management has increased dramatically in the US over the past two decades. However, pain patients are often undertreated due to a variety of physician- and patient-related concerns and barriers.

In addition, despite the pain-relieving properties of opioid medications, the potential for abuse remains a concern. In response to this apprehension about opioid misuse, overdose, abuse, and addiction, the Food and Drug Administration (FDA) developed the Risk Evaluation and Mitigation Strategy (REMS) to ensure that the benefits outweigh the risks for long-acting and extended-release opioid analgesics.

The activity, Opioid Analgesics Risk Evaluation and Mitigation Strategy (REMS): Education for Healthcare Providers, incorporates the REMS blueprint into education that is designed to induce changes in knowledge, competence, and performance that will translate into improved quality of patient care and reduced pain for patients.
Learning Objectives

At the conclusion of this activity, participants should be able to demonstrate the ability to:

Describe components of an effective treatment plan, such as treatment goals, patient interactions, and collaboration with the healthcare team
Compare the individualized benefits and risks to initiating non-medication therapies before considering long-term medications
Identify patients who are candidates for treatment with nonopioid pharmacologic analgesics
Justify a rational decision to initiate long-term opioid analgesics, including ER/LA opioids, with consideration to providing in-home naloxone
Categorize risk factors and vulnerabilities associated with addiction to opioid analgesics

Expiration

Dec 21, 2019

Discipline(s)

Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME

Format

Online, Webinar / Webcast / Video

Credits / Hours

3.0

Accreditation

ACCME, ANCC, ACPE, AANP

Presenters / Authors / Faculty

Lynn R. Webster, MD

Vice President of Scientific Affairs
PRA Health Services
Salt Lake City, UT
Bill McCarberg, MD

Adjunct Assistant Clinical Professor
University of California
San Diego, CA
Jeffrey Fudin, PharmD, DAIPM, FCCP, FASHP, FFSMB

Chief Executive Officer
Remitigate, LLC
Delmar, NY
Clinical Pharmacy Specialist
Director, PGY-2 Pharmacy Pain Residency Program
Stratton Veterans Administration Medical Center
Albany NY

Activity Specialities / Related Topics

Emergency Medicine, Family Medicine, Internal Medicine, Pain Management, Primary Care

Sponsors / Supporters / Grant Providers

This educational activity is supported by an independent educational grant from the Extended-Release/Long-Acting Opioid Analgesic REMS Program Companies.

Keywords / Search Terms

Relias LLC Opioid, REMS, prescription, analgesic, pain management Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map